MyAverix Finance MyAverix Finance

STU

Takeda Pharmaceutical Company Limited (TKDA)

Takeda Pharmaceutical Company Limited (TKDA) is listed on STU. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for TKDA

P/E ratio
18.00

Takeda Pharmaceutical Company Limited (TKDA) — FAQ

What is TKDA's P/E ratio?

The price-to-earnings (P/E) ratio for Takeda Pharmaceutical Company Limited (TKDA) is 18.00 (data as of 2026-05-23).

Does Takeda Pharmaceutical Company Limited pay a dividend?

Dividend yield is not available in the current snapshot for Takeda Pharmaceutical Company Limited (TKDA). Check the MyAverix Finance app for the latest dividend data.

What exchange is TKDA listed on?

TKDA is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play